F. A. Scaraggi

A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors

Elena Santagostino, Maria Elisa Mancuso, Angiola Rocino et al. · Journal of Thrombosis and Haemostasis · 2006 · 164 citations

Medicine, Hematology, Pharmacotherapy +12

Relationship between Factor VII Activity and Clinical Efficacy of Recombinant Factor VIIa Given by Continuous Infusion to Patients with Factor VIII Inhibitors

Massimo Morfini, Angiola Rocino, F. Baudo et al. · Thrombosis and Haemostasis · 2001 · 110 citations

Medicine, Hematology, Surgery +17

Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres

Massimo Morfini, G. Auerswald, Rainer Kobelt et al. · Haemophilia · 2007 · 85 citations · Full text

Medicine, Hematology, Pharmacology +11

Patients With Type 3 Severe von Willebrand Disease Are Not Protected Against Atherosclerosis

A. Šrámek, Paolo Bucciarelli, Augusto B. Federici et al. · Circulation · 2004 · 59 citations · Full text

Medicine, Cardiology, Molecular Pathology +15

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women

V. De Mitrio, Giovanni De Pergola, Roberto Vettor et al. · Metabolism · 1999 · 39 citations

Medicine, Endocrinology, Metabolic Regulation +7